BIN1 has been repeatedly identified as one of the major genetic risk factors for Alzheimer’s disease, where its dysregulation contributes to abnormal membrane remodeling, Tau pathology, and synaptic loss [37,38,39]. Here, MAPT is linked to Alzheimer disease.